Atlas Pharmaceuticals Glycopyrrolate, 0.4mg/mL (3 products)
Recall announced June 16, 2021 by Atlas Pharmaceuticals, LLC, posted by the U.S. Food and Drug Administration (FDA). Reason: Lack of Assurance of Sterility. The agency has closed this recall.
- Where sold
- Nationwide
- Last updated
- November 19, 2026
Products included
- Glycopyrrolate, 0.4mg/mL, (12mg/30 mL), Atlas Pharmaceuticals, LLC, 711 E. Carefree Hwy, Suite 107, Phoenix, AZ, 85085, (844) 661-1829, www.atlasdrugs.com, For IM or IV administration. (Lot S-60388, Exp 2021-10-31)
- BUPRENORPHINE, 0.15 mg/mL, (4.5/30mL), C-III, Atlas Pharmaceuticals, LLC, 711 E. Carefree Hwy, Suite 107, Phoenix, AZ, 85085, (844) 661-1829, www.atlasdrugs.com. (Lots S-60355, Exp 2021-06-16; S-60357, Exp 2021-06-17; S-60360, Exp 2021-06-18; S-60365, Exp 2020-06-30; S-60384, Exp 2021-11-19; S-60385, Exp 2021-11-20; S-60389, Exp 2021-12-01; S-60408, Exp 2021-12-31 and S-60412, Exp 2021-12-31. S-60414 - 2021-12-31 S-60415 - 2021-12-31 S-60422 - 2021-12-31 S-60424 - 2021-12-31)
- BUPRENORPHINE, 0.6 mg/mL, (9mg/15 mL) C-III, Atlas Pharmaceuticals, LLC, 711 E. Carefree Hwy, Suite 107, Phoenix, AZ, 85085, (844) 661-1829, www.atlasdrugs.com. (Lots S-60354, Exp 2021-06-16; S-60356, Exp 2021-06-17; S-60359, Exp 2021-06-18; S-60364, Exp 2021-06-30; S-60380, Exp 2021-11-09; S-60381, Exp 2021-11-10; S-60383, Exp 2021-11-19 S-60386, Exp 2021-11-25; S-60387, Exp 2021-11-27; S-60390, Exp 2021-12-01; S-60392, Exp 2021-12-03; S-60407, Exp 2021-12-31; S-60420, Exp 2021-12-31; S-60421, Exp 2021-12-31; S-60423, Exp 2021-12-31; S-60425, Exp 2021-12-31; S-60426, Exp 2021-12-31.)
Read the official notice. Always compare the codes on your package with the official notice. It is the final word.
Has your pet used this product and seems unwell? Call your veterinarian or an emergency animal hospital now.
